Literature DB >> 23817570

A genome-wide association study identifies two new cervical cancer susceptibility loci at 4q12 and 17q12.

Yongyong Shi1, Li Li, Zhibin Hu, Shuang Li, Shixuan Wang, Jihong Liu, Chen Wu, Lin He, Jianfeng Zhou, Zhiqiang Li, Ting Hu, Yile Chen, Yao Jia, Shaoshuai Wang, Li Wu, Xiaodong Cheng, Zhijun Yang, Ru Yang, Xiong Li, Kecheng Huang, Qinghua Zhang, Hang Zhou, Fangxu Tang, Zhilan Chen, Jian Shen, Jie Jiang, Hu Ding, Hui Xing, Shulan Zhang, Pengpeng Qu, Xiaojie Song, Zhongqiu Lin, Dongrui Deng, Ling Xi, Weiguo Lv, Xiaobing Han, Guangshi Tao, Lixing Yan, Zhedong Han, Zhuang Li, Xiaoping Miao, Shandong Pan, Yuanming Shen, Hui Wang, Dan Liu, Ee Gong, Zheng Li, Limei Zhou, Xiaomei Luan, Chuping Wang, Qian Song, Sufang Wu, Hongbin Xu, Jiawei Shen, Fulin Qiang, Gang Ma, Li Liu, Xiaojun Chen, Jibin Liu, Jiangping Wu, Yan Shen, Yang Wen, Minjie Chu, Jiang Yu, Xiaoxia Hu, Yujuan Fan, Hongying He, Yanming Jiang, Zhiying Lei, Cui Liu, Jianhua Chen, Yuan Zhang, Cunjian Yi, Shuangyun Chen, Wenjin Li, Daowen Wang, Zehua Wang, Wen Di, Keng Shen, Dongxin Lin, Hongbing Shen, Youji Feng, Xing Xie, Ding Ma.   

Abstract

To identify new genetic risk factors for cervical cancer, we conducted a genome-wide association study in the Han Chinese population. The initial discovery set included 1,364 individuals with cervical cancer (cases) and 3,028 female controls, and we selected a 'stringently matched samples' subset (829 cases and 990 controls) from the discovery set on the basis of principal component analysis; the follow-up stages included two independent sample sets (1,824 cases and 3,808 controls for follow-up 1 and 2,343 cases and 3,388 controls for follow-up 2). We identified strong evidence of associations between cervical cancer and two new loci: 4q12 (rs13117307, Pcombined, stringently matched=9.69×10(-9), per-allele odds ratio (OR)stringently matched=1.26) and 17q12 (rs8067378, Pcombined, stringently matched=2.00×10(-8), per-allele ORstringently matched=1.18). We additionally replicated an association between HLA-DPB1 and HLA-DPB2 (HLA-DPB1/2) at 6p21.32 and cervical cancer (rs4282438, Pcombined, stringently matched=4.52×10(-27), per-allele ORstringently matched=0.75). Our findings provide new insights into the genetic etiology of cervical cancer.

Entities:  

Mesh:

Year:  2013        PMID: 23817570     DOI: 10.1038/ng.2687

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  41 in total

1.  Data analysis of HLA sequencing using Assign-SBT v3.6+ from Conexio.

Authors:  Carla Wirtz; David Sayer
Journal:  Methods Mol Biol       Date:  2012

2.  Principal components analysis corrects for stratification in genome-wide association studies.

Authors:  Alkes L Price; Nick J Patterson; Robert M Plenge; Michael E Weinblatt; Nancy A Shadick; David Reich
Journal:  Nat Genet       Date:  2006-07-23       Impact factor: 38.330

3.  Nef is physically recruited into the immunological synapse and potentiates T cell activation early after TCR engagement.

Authors:  David Fenard; Wes Yonemoto; Carlos de Noronha; Marielle Cavrois; Samuel A Williams; Warner C Greene
Journal:  J Immunol       Date:  2005-11-01       Impact factor: 5.422

4.  Members of a novel gene family, Gsdm, are expressed exclusively in the epithelium of the skin and gastrointestinal tract in a highly tissue-specific manner.

Authors:  Masaru Tamura; Shigekazu Tanaka; Tomoaki Fujii; Aya Aoki; Hiromitu Komiyama; Kiyoshi Ezawa; Kenta Sumiyama; Tomoko Sagai; Toshihiko Shiroishi
Journal:  Genomics       Date:  2007-03-12       Impact factor: 5.736

5.  Spontaneous regression of grade 3 vulvar intraepithelial neoplasia associated with human papillomavirus-16-specific CD4(+) and CD8(+) T-cell responses.

Authors:  Isabelle Bourgault Villada; Micheline Moyal Barracco; Isabelle Bourgault Villada; Micheline Moyal Barracco; Marianne Ziol; Aude Chaboissier; Nathalie Barget; Sophie Berville; Bernard Paniel; Eric Jullian; Thierry Clerici; Bernard Maillère; Jean Gérard Guillet
Journal:  Cancer Res       Date:  2004-12-01       Impact factor: 12.701

Review 6.  The epidemiology of human papillomavirus infections.

Authors:  Janet G Baseman; Laura A Koutsky
Journal:  J Clin Virol       Date:  2005-03       Impact factor: 3.168

7.  GASDERMIN, suppressed frequently in gastric cancer, is a target of LMO1 in TGF-beta-dependent apoptotic signalling.

Authors:  N Saeki; D H Kim; T Usui; K Aoyagi; T Tatsuta; K Aoki; K Yanagihara; M Tamura; H Mizushima; H Sakamoto; K Ogawa; M Ohki; T Shiroishi; T Yoshida; H Sasaki
Journal:  Oncogene       Date:  2007-04-30       Impact factor: 9.867

8.  Immune factors involved in the cervical immune response in the HIV/HPV co-infection.

Authors:  A F Nicol; G J Nuovo; A Salomão-Estevez; B Grinsztejn; B Grinsztein; A Tristão; F Russomano; J R Lapa E Silva; M P Oliveira; C Pirmez
Journal:  J Clin Pathol       Date:  2007-05-04       Impact factor: 3.411

9.  Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels.

Authors:  Richa Saxena; Benjamin F Voight; Valeriya Lyssenko; Noël P Burtt; Paul I W de Bakker; Hong Chen; Jeffrey J Roix; Sekar Kathiresan; Joel N Hirschhorn; Mark J Daly; Thomas E Hughes; Leif Groop; David Altshuler; Peter Almgren; Jose C Florez; Joanne Meyer; Kristin Ardlie; Kristina Bengtsson Boström; Bo Isomaa; Guillaume Lettre; Ulf Lindblad; Helen N Lyon; Olle Melander; Christopher Newton-Cheh; Peter Nilsson; Marju Orho-Melander; Lennart Råstam; Elizabeth K Speliotes; Marja-Riitta Taskinen; Tiinamaija Tuomi; Candace Guiducci; Anna Berglund; Joyce Carlson; Lauren Gianniny; Rachel Hackett; Liselotte Hall; Johan Holmkvist; Esa Laurila; Marketa Sjögren; Maria Sterner; Aarti Surti; Margareta Svensson; Malin Svensson; Ryan Tewhey; Brendan Blumenstiel; Melissa Parkin; Matthew Defelice; Rachel Barry; Wendy Brodeur; Jody Camarata; Nancy Chia; Mary Fava; John Gibbons; Bob Handsaker; Claire Healy; Kieu Nguyen; Casey Gates; Carrie Sougnez; Diane Gage; Marcia Nizzari; Stacey B Gabriel; Gung-Wei Chirn; Qicheng Ma; Hemang Parikh; Delwood Richardson; Darrell Ricke; Shaun Purcell
Journal:  Science       Date:  2007-04-26       Impact factor: 47.728

10.  Genetic analysis of in vitro progression of human papillomavirus-transfected human cervical cells.

Authors:  T M Chen; G Pecoraro; V Defendi
Journal:  Cancer Res       Date:  1993-03-01       Impact factor: 12.701

View more
  56 in total

Review 1.  Genome-Wide Association Studies of Cancer in Diverse Populations.

Authors:  Sungshim L Park; Iona Cheng; Christopher A Haiman
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2017-06-21       Impact factor: 4.254

2.  HLA-DP is the cervical cancer susceptibility loci among women infected by high-risk human papillomavirus: potential implication for triage of human papillomavirus-positive women.

Authors:  Meiqun Jia; Jing Han; Dong Hang; Jie Jiang; Minjie Wang; Baojun Wei; Juncheng Dai; Kai Zhang; Lanwei Guo; Jun Qi; Hongxia Ma; Jufang Shi; Jiansong Ren; Zhibin Hu; Min Dai; Ni Li
Journal:  Tumour Biol       Date:  2015-12-28

3.  The D2 and D3 Sublineages of Human Papilloma Virus 16-Positive Cervical Cancer in Guatemala Differ in Integration Rate and Age of Diagnosis.

Authors:  Hong Lou; Joseph F Boland; Edmundo Torres-Gonzalez; Anaseidy Albanez; Weiyin Zhou; Mia K Steinberg; Lena Diaw; Jason Mitchell; David Roberson; Michael Cullen; Lisa Garland; Sara Bass; Robert D Burk; Meredith Yeager; Nicolas Wentzensen; Mark Schiffman; Enrique Alvirez Freites; Eduardo Gharzouzi; Lisa Mirabello; Michael Dean
Journal:  Cancer Res       Date:  2020-07-06       Impact factor: 12.701

4.  TGFβ receptor 1: an immune susceptibility gene in HPV-associated cancer.

Authors:  Chaya Levovitz; Dan Chen; Emma Ivansson; Ulf Gyllensten; John P Finnigan; Sara Alshawish; Weijia Zhang; Eric E Schadt; Marshal R Posner; Eric M Genden; Paolo Boffetta; Andrew G Sikora
Journal:  Cancer Res       Date:  2014-10-01       Impact factor: 12.701

5.  A significant association between rs8067378 at 17q12 and invasive cervical cancer originally identified by a genome-wide association study in Han Chinese is replicated in a Japanese population.

Authors:  Kiyonori Miura; Hiroyuki Mishima; Michio Yasunami; Masanori Kaneuchi; Michio Kitajima; Shuhei Abe; Ai Higashijima; Naoki Fuchi; Shoko Miura; Koh-Ichiro Yoshiura; Hideaki Masuzaki
Journal:  J Hum Genet       Date:  2016-05-19       Impact factor: 3.172

6.  Expression quantitative trait loci in long non-coding RNA ZNRD1-AS1 influence cervical cancer development.

Authors:  Lanwei Guo; Juan Wen; Jing Han; Jie Jiang; Shuanghua Xie; Xiaoshuang Feng; Baojun Wei; Juncheng Dai; Kai Zhang; Jun Qi; Hongxia Ma; Jufang Shi; Jiansong Ren; Yue Zhang; Min Dai; Zhibin Hu; Ni Li
Journal:  Am J Cancer Res       Date:  2015-06-15       Impact factor: 6.166

Review 7.  The molecular mechanism of human papillomavirus-induced carcinogenesis in head and neck squamous cell carcinoma.

Authors:  Daisuke Sano; Nobuhiko Oridate
Journal:  Int J Clin Oncol       Date:  2016-06-23       Impact factor: 3.402

8.  A population-based case-control study of genetic variation in cytokine genes associated with risk of cervical and vulvar cancers.

Authors:  Sheetal Hardikar; Lisa G Johnson; Mari Malkki; Effie W Petersdorf; Denise A Galloway; Stephen M Schwartz; Margaret M Madeleine
Journal:  Gynecol Oncol       Date:  2015-08-01       Impact factor: 5.482

9.  Expression quantitative trait loci in long non-coding RNA PAX8-AS1 are associated with decreased risk of cervical cancer.

Authors:  Jing Han; Wen Zhou; Meiqun Jia; Juan Wen; Jie Jiang; Jufang Shi; Kai Zhang; Hongxia Ma; Jibin Liu; Jiansong Ren; Min Dai; Zhibin Hu; Dong Hang; Ni Li; Hongbing Shen
Journal:  Mol Genet Genomics       Date:  2016-05-25       Impact factor: 3.291

10.  A high-resolution HLA imputation system for the Taiwanese population: a study of the Taiwan Biobank.

Authors:  Yu-Han Huang; Seik-Soon Khor; Xiuwen Zheng; Hsuan-Yu Chen; Ya-Hsuan Chang; Hou-Wei Chu; Pei-Ei Wu; Yu-Ju Lin; Shu-Fen Liao; Chen-Yang Shen; Katsushi Tokunaga; Mei-Hsuan Lee
Journal:  Pharmacogenomics J       Date:  2020-02-11       Impact factor: 3.550

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.